Doctors Note Logo

Published on: 10/26/2026

Cymbalta's Hardest Side Effects, and Why Stopping Needs a Plan

Cymbalta (duloxetine) is linked to several difficult side effects, including nausea, insomnia, heavy sweating, fatigue, sexual dysfunction, appetite changes, and in some people raised blood pressure or liver strain. Stopping suddenly can trigger discontinuation symptoms such as "brain zaps," dizziness, irritability, crying spells, and flu-like aches, which is why tapering should follow a plan set with a prescriber. Dose, length of use, and individual sensitivity all change how hard the process feels, so there are several important factors to consider before making any change, explained below.

Because withdrawal effects and medication side effects can look a lot like a return of depression, anxiety, or an unrelated health issue, sorting out what you are actually feeling is the first step toward a safe next move. Take a free, instant, online symptom check to clarify your symptoms and get guidance on how urgently to talk with a clinician.

Last reviewed for medical accuracy: 10/22/2026

answer background

Concerned about your symptoms?

Explanation

Cymbalta’s Hardest Side Effects, and Why Stopping Needs a Plan

Cymbalta (duloxetine) is a widely prescribed antidepressant and nerve‐pain medication. Like all medications, it carries potential side effects—some mild and temporary, others rare but serious. Understanding what the worst side effects of Cymbalta can be, and why you need a careful taper plan to stop, helps you stay informed and safe.


What Are the Worst Side Effects of Cymbalta?

While many people tolerate Cymbalta well, a small number experience severe reactions. Below is a breakdown from more common to rare but dangerous:

1. Suicidal Thoughts or Behaviors

  • Who’s at risk?
    Especially young adults (under 25) during early treatment or dose changes.
  • Signs to watch for:
    Worsening depression, new anxiety, agitation, panic attacks, or talking about self-harm.
  • Action:
    Seek immediate medical attention if you notice any of these.

2. Serotonin Syndrome

  • How it happens:
    Too much serotonin in the brain, often from combining Cymbalta with other serotonergic drugs (e.g., other antidepressants, migraine medications).
  • Key symptoms:
    • High body temperature
    • Rapid heartbeat
    • Extreme sweating
    • Shaking or muscle rigidity
    • Agitation, confusion
  • Why it matters:
    Serotonin syndrome can be life-threatening. Call emergency services if you suspect it.

3. Liver Injury

  • Who’s at risk?
    People with pre-existing liver disease or heavy alcohol use.
  • What to look for:
    Yellowing of eyes/skin (jaundice), dark urine, severe fatigue, abdominal pain.
  • Next steps:
    Stop Cymbalta and see your doctor right away if you notice these signs.

4. High Blood Pressure and Heart Rate

  • Potential effects:
    Cymbalta can raise your blood pressure or heart rate, sometimes without obvious symptoms.
  • Monitoring:
    Regularly check your blood pressure, especially if you have hypertension or heart disease.

5. Hyponatremia (Low Sodium)

  • Who’s at risk?
    Older adults, those also taking diuretics or other medications that affect sodium.
  • Symptoms:
    Headache, confusion, weakness, seizures in severe cases.
  • Action:
    Your doctor may check blood sodium levels if you feel unusually weak or confused.

6. Severe Allergic Reactions

  • Warning signs:
    Rash, hives, swelling of face or throat, difficulty breathing.
  • Urgency:
    Anaphylaxis is medical emergency—call 911 immediately.

7. Angle-Closure Glaucoma

  • What happens:
    Sudden eye pain, blurred vision, nausea.
  • Who’s at risk?
    People with narrow drainage angles in the eye.
  • What to do:
    Seek urgent ophthalmology care to prevent vision loss.

8. Severe Skin Reactions

  • Types:
    Stevens-Johnson syndrome, toxic epidermal necrolysis.
  • Symptoms:
    Widespread rash, blistering, peeling skin, fever.
  • Action:
    Stop Cymbalta and get immediate medical help.

Other Notable Side Effects

These are more common but can still significantly impact day-to-day life:

  • Nausea, Vomiting
  • Dry Mouth
  • Constipation or Diarrhea
  • Fatigue or Drowsiness
  • Insomnia or Vivid Dreams
  • Dizziness or Lightheadedness
  • Sexual Dysfunction (reduced libido, erectile issues)
  • Increased Sweating
  • Loss of Appetite or Weight Changes

Many of these improve over weeks. Talk with your doctor if they persist or interfere with activities.


Why Stopping Cymbalta Needs a Plan

Abruptly stopping Cymbalta often leads to discontinuation syndrome, which can feel alarming:

Common Discontinuation Symptoms

  • “Brain zaps” (electric shock sensations in the head)
  • Dizziness or lightheadedness
  • Nausea or headache
  • Irritability, mood swings
  • Fatigue or sleep disturbances
  • Flu-like symptoms (chills, muscle aches)

These usually begin within a few days of stopping and can last weeks or longer if not managed properly.

The Importance of a Taper Plan

  1. Gradual Dose Reduction
    Slowly lowering your dose over weeks to months lets your brain chemistry adjust.
  2. Symptom Monitoring
    Track any new or worsening symptoms in a journal or app.
  3. Regular Check-Ins
    Stay in touch with your prescribing doctor or mental health provider.
  4. Flexibility
    Be prepared to slow the taper if symptoms become too intense.

A well-structured taper decreases the intensity of discontinuation symptoms and helps prevent relapse of depression or anxiety.


Tips for Managing Side Effects and Discontinuation

  • Stay Hydrated and Eat Regularly
    Helps combat nausea, dizziness, and electrolyte imbalances.
  • Monitor Blood Pressure
    Keep a home cuff if you have cardiovascular risk.
  • Practice Stress-Reduction
    Deep breathing, gentle yoga, or mindfulness can ease anxiety and help with sleep.
  • Seek Support
    Talk to friends, family, or a support group about what you’re experiencing.
  • Use a Symptom Checker
    If you’re unsure how serious a side effect is, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

When to Seek Immediate Medical Help

Speak to a doctor or call emergency services if you experience any of the following:

  • Signs of serotonin syndrome (high fever, rapid heartbeat, severe agitation)
  • Suicidal thoughts, new or worsening self-harm ideas
  • Severe allergic reaction (swelling of face/throat, trouble breathing)
  • Sudden vision changes or severe eye pain
  • Jaundice (yellowing skin/eyes), dark urine

For any life-threatening or serious concerns, always prioritize professional medical care.


Final Thoughts

Cymbalta can be an effective tool against depression, anxiety, and nerve pain—but like all medications, it carries risks. By knowing what the worst side effects of Cymbalta are, and why stopping without a plan can backfire, you position yourself to make safer choices.

Before making any changes:

  • Talk with your prescribing physician.
  • Use reliable tools like Ubie’s symptom checker to guide you.
  • Never stop Cymbalta abruptly on your own.

If you ever feel overwhelmed or notice alarming symptoms, speak to a doctor right away. Your safety and well-being come first.

(References)

  • * Boehmerle W, Huehnchen P, Endres M. [Chemotherapy-induced neuropathy]. Nervenarzt. 2015 Feb;86(2):156-60. doi: 10.1007/s00115-014-4126-3. PMID: 25586233.

  • * Buoli M, Serati M, Cahn W. Alternative pharmacological strategies for adult ADHD treatment: a systematic review. Expert Rev Neurother. 2016;16(2):131-44. doi: 10.1586/14737175.2016.1135735. Epub 2016 Jan 14. PMID: 26693882.

  • * Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J. Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review. Psychother Psychosom. 2018;87(4):195-203. doi: 10.1159/000491524. Epub 2018 Jul 17. PMID: 30016772.

  • * Drugs for anxiety disorders. Med Lett Drugs Ther. 2019 Aug 12;61(1578):121-126. PMID: 31386647.

  • * Nonopioid drugs for pain. Med Lett Drugs Ther. 2022 Mar 7;64(1645):33-40. PMID: 35231019.

  • * Kishi T, Ikuta T, Sakuma K, Okuya M, Hatano M, Matsuda Y, Iwata N. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Mol Psychiatry. 2023 Jan;28(1):402-409. doi: 10.1038/s41380-022-01824-z. Epub 2022 Oct 17. PMID: 36253442; PMCID: PMC9812779.

  • * Birkinshaw H, Friedrich CM, Cole P, Eccleston C, Serfaty M, Stewart G, White S, Moore RA, Phillippo D, Pincus T. Antidepressants for pain management in adults with chronic pain: a network meta-analysis. Cochrane Database Syst Rev. 2023 May 10;5(5):CD014682. doi: 10.1002/14651858.CD014682.pub2. Epub 2023 May 10. PMID: 37160297; PMCID: PMC10169288.

  • * Drugs for migraine. Med Lett Drugs Ther. 2023 Jun 12;65(1678):89-96. doi: 10.58347/tml.2023.1678a. PMID: 37266987.

  • * Migliorini F, Maffulli N, Eschweiler J, Baroncini A, Bell A, Colarossi G. Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis. J Orthop Surg Res. 2023 Jul 17;18(1):504. doi: 10.1186/s13018-023-03995-z. Epub 2023 Jul 17. PMID: 37461044; PMCID: PMC10351165.

  • * Bragg S, Marrison ST, Haley S. Diabetic Peripheral Neuropathy: Prevention and Treatment. Am Fam Physician. 2024 Mar;109(3):226-232. PMID: 38574212.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.